INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Inspire Medical Systems, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$70.15+1.36 (+1.98%)
Close on Oct 19, 2026
- Market cap
- $2.03B
- P/E (TTM)
- 15.2
- Dividend yield
- –
Inspire Medical Systems, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $872.09M | $771.04M | $606.18M | $394.83M | $220.98M | $106.11M | $73.66M | $44.38M | $24.29M | $13.79M | 95.6% | +13.1% |
| International | $39.90M | $31.76M | $18.62M | $13.02M | – | – | – | – | – | – | 4.4% | +25.6% |
| Europe | – | – | – | – | – | $9.27M | $8.39M | $6.22M | $4.27M | $2.64M | – | – |
| All other countries | – | – | $18.62M | $13.02M | $12.42M | $9.27M | $8.39M | – | – | – | – | – |
From the segment and revenue-disaggregation notes of Inspire Medical Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.